Home > Financial Ratios > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
EBIT Growth

    Back to All Ratios
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year EBIT Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Growth(%) -13.76-27.84-15.3241.0512.11

What is the latest EBIT Growth ratio of SUVEN PHARMACEUTICALS ?

The latest EBIT Growth ratio of SUVEN PHARMACEUTICALS is -13.76 based on Mar2025 Consolidated results.
Year EBIT Growth
Mar2025-13.76
Mar2024-27.84
Mar2023-15.32
Mar202241.05
Mar202112.11

How is EBIT Growth of SUVEN PHARMACEUTICALS Trending?

Years EBIT Growth % Change
Mar2025 -13.76
Negative
Mar2024 -27.84
Negative
Mar2023 -15.32
Negative
Mar2022 41.05
238.98
Mar2021 12.11 -

Other Financial Ratios of SUVEN PHARMACEUTICALS


Compare EBIT Growth ratio of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹12,490.0 Cr -6.9% -18.3% -70.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-6.9%

-18.3%

-70.6%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses